Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pronova BioPharma

1837 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
4 FINANCING ROUNDS
Description

Developer lipid therapies. The company develops and manufactures marine originated omega-3 derived pharmaceutical products.

Formerly Known As
Pronova Biocare
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Vollsveien 6
  • 1366 Oslo
  • Norway

+47 22 00 00 00

Pronova BioPharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pronova BioPharma‘s full profile, request access.

Request full access to PitchBook

Pronova BioPharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Pronova BioPharma‘s full profile, request access.

Request full access to PitchBook

Pronova BioPharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Morten Jurs Chief Executive Officer

2 Former Executives

You’re viewing 1 of 3 executives. Get the full list »